Cargando…
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to scale up around the world, costing severe health and economic losses. The development of an effective COVID-19 vaccine is of utmost importance. Most vaccine designs ca...
Autores principales: | Jiang, Hu-Dachuan, Li, Jing-Xin, Zhang, Peng, Huo, Xiang, Zhu, Feng-Cai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057314/ http://dx.doi.org/10.1097/ID9.0000000000000003 |
Ejemplares similares
-
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Where are we now?
Publicado: (1977) -
Vaccines against Tuberculosis: Where Are We Now?
por: Srivastava, Shruti, et al.
Publicado: (2023) -
Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023) -
Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)